Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Olive Oil is a biotechnology company that produces extra virgin olive oil.
Ananya Health develops a medical device for treating cervical pre-cancer.
Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Monon Bioventures is a privately held company created to assist world-class investigators
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.
Voximetry is a healthtech software company that aims to give many cancer patients an alternative to chemotherapy.
TumorGen is a biotechnology company.
Telehealth Research Center of Excellence is a cancer center that is engaged in improving cancer-related care and outcomes.
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.
Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Flexomics helps to bridge genomic and functional analysis.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Histolix provides an intrinsically digital and slide-free histopathology solution.
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Immunicom is a biotechnology company.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Matter Bio operates as company focus on preserving genome integrity.
National Cancer Institute has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Health Care, Life Science, Pharmaceutical, Medical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Quiver Bioscience received $9.3M in a Grant round. National Cancer Institute's total known invested capital is $294.4M.
National Cancer Institute's average investment size is $3.6M across its portfolio of 99 companies.
Recent National Cancer Institute portfolio additions include Allterum Therapeutics, Navrogen, Oleolive, Ananya Health, Palm Therapeutics. These companies were founded in 2020 or later.